sirolimus
美 
英
例句
However, sirolimus stents fared better than paclitaxel stents in terms of MI, target vessel revascularization, and late thrombosis.
在心梗、靶血管的血运重建和晚期血栓文面，西罗莫司支架优于紫杉醇支架。
Stent thrombosis after 1 year was more common with both sirolimus-eluting stents and paclitaxel-eluting stents than with bare-metal stents.
与裸金属支架组相比，1年后雷帕霉素和紫杉醇药物涂层支架组更容易发生血栓。
Drug discontinuation due to an adverse event was also more frequent in the sirolimus cohort compared to those patients continued on CNI.
在西罗莫司组中因不良事件而导致停药的也多于继续使用CNI治疗的患者。
Therapeutic drug monitoring should not be the sole basis for adjusting sirolimus therapy.
治疗药物监测不应作为调整西罗莫司治疗的唯一根据。
Kushwaha and colleagues tested the use of sirolimus as an alternative anti-proliferative immunosuppressant drug.
Kushwaha和他的同事试验西罗莫司作为可选择的抗增值免疫抑制药物的使用。
A novel, simple and cost effective assay for monitoring blood levels of rapamycin (sirolimus) and rapamycin analogues was developed.
我们开发了一项用于检测血液中雷帕霉素（西罗莫司）和雷帕霉素类似物浓度的简便、经济节省的新型分析方法。
Sirolimus is indicated for the prophylaxis of organ rejection in patients aged 13 years or older receiving kidney transplants.
西罗莫司用于在13岁及以上接受肾移植患者中预防器官排斥反应。
At this time, FDA has not made any changes to the professional label for sirolimus.
目前，FDA尚未对西罗莫司的专业标签信息做出任何修改。
Sirolimus monotherapy may be safe, but experience is limited and side effects such as hyperlipidemia must be monitored.
西罗莫斯单一治疗可能安全，但是治疗经验有限并且需要监测高脂血症的副作用。
In all 4 patients, sirolimus-induced pneumonitis resolved following cessation of therapy but took weeks to months for complete recovery.
全部4名患者的西罗莫司诱导性肺炎都在治疗结束得到消散，但数周至数月后才完全康复。
Beyond 2 years, the increase in plaque volume, but not plaque index, was significantly lower with sirolimus than calcineurin inhibitors.
超过两年，使用西罗莫林的患者比使用神经钙蛋白抑制因子的患者在斑块体积而不是斑块指数上的增大很大程度上要小的多。
Objective To observe the effect of application of Sirolimus on adventitia in preventing stenosis of vein graft.
目的探讨血管外膜应用西罗莫司对静脉移植物再狭窄的作用。
Sirolimus is a kind of macrolide antibiotics as well as immunosuppressant.
西罗莫司是一种大环内酯类抗生素，为一种免疫抑制剂。
The FDA is determining whether a labeling change for sirolimus is needed.
FDA正在酝酿是否需要修改西罗莫司的标签信息。
The effect of sirolimus, a new immunosuppressant, on vaccine responses has been little studied.
西罗莫司（一种新的免疫抑制剂）对于接种疫苗应答影响的研究尚少。
Immunosuppression included de noo sirolimus, low-dose calcineurin inhibitor for 6 to 12 months, with short-course (3 months) or no steroids.
免疫抑制方案包括术后起始即用西罗莫司、低剂量钙调蛋白抑制剂使用6-12个月，联用短程（3个月）或者不使用激素。
The synergic effects of sirolimus and immature dendritic cells in prolonging survival time of skin allograft in mice
西罗莫司与未成熟树突状细胞延长小鼠皮肤移植存活时间的协同作用
Determination of the plasma sirolimus concentrations in patients after renal transplantation by HPLC method
HPLC法检测肾移植病人全血中西罗莫司的药物浓度
Study of sirolimus-eluting stent in treatment of elderly pretty long coronary artery lesions
雷帕霉素洗脱支架治疗老年冠状动脉特长病变的临床研究
Sirolimus inhibits the differentiation, proliferation and migration of endothelial progenitor cells in vitro
雷帕霉素对内皮祖细胞增殖、黏附及迁移能力影响的实验研究
Analysis of acute and subacute stent thrombosis after successful implantation of sirolimus-eluting stent in complex coronary lesions
复杂冠状动脉病变西罗莫司洗脱支架置入后急性和亚急性支架内血栓形成情况分析
Comparison of the application of sirolimus eluting stents and paclitaxel eluting stents in coronary lesions
西罗莫司和紫杉醇药物洗脱支架治疗冠状动脉疾病的对比研究
Nine cases of conversion from calcineurin inhibitor to sirolimus in the treatment of urological neoplasm in kidney allograft recipients
肾移植后泌尿系统肿瘤患者应用西罗莫司替代钙调磷酸酶抑制剂九例
Clinical observation on sirolimus- eluting stent implantation in left main coronary artery bifurcation lesions
左主干末端病变选择性雷帕霉素洗脱支架术临床评价
One-year clinical outcomes of domestic sirolimus-eluting stent in treating unselected patients with coronary artery disease
国产与进口西罗莫司药物洗脱支架治疗冠心病临床疗效对比
The clinical efficacy of sirolimus-eluting stents versus paclitaxel-eluting stents in complex and diffuse coronary lesions
两种药物洗脱支架在冠状动脉复杂弥漫病变中的疗效比较
Clinical and angiographic follow-up observation of sirolimus-eluting stents in the treatment of complex coronary lesions
雷帕霉素洗脱支架治疗冠状动脉长病变的随访观察
Short-term clinical observation of low-dose sirolimus in living relative kidney transplantation from elderly donor
接受老龄亲属活体供肾移植者采用小剂量西罗莫司的近期临床观察
Evaluation of clinical outcomes of sirolimus-eluting stents treated to coronary bifurcation lesions
雷帕霉素洗脱支架治疗冠状动脉分叉病变的临床疗效评价
The impact of expansion of sirolimus eluting stent on intimal hyperplasia: an intravascular ultrasound study
雷帕霉素洗脱支架扩张程度对内膜增生影响的血管内超声研究
Sirolimus-eluting stents with modified T-stenting technique for reverse crushing on bifurcation lesions
改良T型药物洗脱支架置入术治疗冠状动脉分叉病变
Determination of peroxide value in sirolimus oral solution by potentiometric-iodometry
碘量法电位滴定西罗莫司口服溶液剂的过氧化值
The Efficacy of Sirolimus-eluting Stents and Bear Metal Stents in Treatment of Atherosclerotic Coronary Lesion
雷帕霉素涂层支架与裸金属支架对冠脉病变的疗效
Compare homemade sirolimus-eluting stent to paclitaxel-eluting stent with clinical effect
国产西罗莫司洗脱支架与紫杉醇洗脱支架临床效果比较研究
Safety and efficacy of sirolimus eluting stent in patients with small renal artery stenotic lesions
小直径肾动脉狭窄应用西罗莫司洗脱支架的安全性和有效性
Comparison of sirolimus eluting stenting versus bare metal stenting in type 2 diabetic patients with very small coronary artery lesions
合并2型糖尿病的冠状动脉小血管病变植入雷帕酶素洗脱支架与金属裸支架疗效比较
Effects of sirolimus on recurrence of cancer after liver transplantation
西罗莫司对肝癌肝移植术后肿瘤复发的抑制作用
Effect of Sirolimus on preventing transplant arteriosclerosis in rats
西罗莫司对移植动脉粥样硬化的预防作用
Advances in the Study of Preventing Coronary Restenosis with Sirolimus Eluting Stent
雷帕霉素涂层支架预防血管内再狭窄的研究进展
Application of Sirolimus-Eluting Stents in Patients with Coronary Artery Disease and Type 2 Diabetes
雷帕霉素洗脱支架在冠心病合并2型糖尿病患者中的应用
